Adolescent
Adult
Antibodies, Monoclonal, Humanized
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Europe
Female
Follow-Up Studies
Humans
Immunoglobulin G
Injections, Subcutaneous
Male
Middle Aged
Multiple Sclerosis, Relapsing-Remitting
Quality of Life
Reference Values
Risk Assessment
Time Factors
Treatment Outcome
Young Adult
